Using Dynamic Oral Dosing of Rifapentine and Rifabutin to Simulate Exposure Profiles of Long-Acting Formulations in a Mouse Model of Tuberculosis Preventive Therapy

Mostrar otras versiones (1)

Administration of tuberculosis preventive therapy (TPT) to individuals with latent tuberculosis infection is an important facet of global tuberculosis control. The use of long-acting injectable (LAI) drug formulations may simplify and shorten regimens for this indication. Rifapentine and rifabutin h...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yong S., Li, Si-Yang, Pertinez, Henry, Betoudji, Fabrice, Lee, Jin, Rannard, Steven P., Owen, Andrew, Nuermberger, Eric L., Ammerman, Nicole C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353356/
https://www.ncbi.nlm.nih.gov/pubmed/37338374
http://dx.doi.org/10.1128/aac.00481-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353356/
https://www.ncbi.nlm.nih.gov/pubmed/37338374
http://dx.doi.org/10.1128/aac.00481-23

Ejemplares similares